Treace Medical Concepts, Inc. (TMCI) stock
Close on Nov 13, 2026Market cap $342.73MP/E –Yield –
Treace Medical Concepts statistics
83 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 26, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 8.08
- 4.81
Enterprise valuationIndustry
- EV / Sales
- 1.79
- 2.60
Share statisticsIndustry
- Shares Change (YoY)
- 2.96%
- 3.32%
- Float
- 47M
- 37M
- Shares Held by Insiders
- 28.0%
- 10.5%
- Shares Held by Institutions
- 49.0%
- 60.5%
Short sellingIndustry
- Short Interest
- 2M
- –
- Short Interest Change
- -6.91%
- -2.57%
- Short % of Float
- 3.82%
- 5.11%
- Short % of Shares Outstanding
- 2.75%
- 3.98%
- Days to Cover
- 8.65
- 3.94
Stock price statisticsIndustry
- 52-Week High
- $5.44
- –
- 52-Week Low
- $1.17
- –
- 20-Day Moving Average
- $4.53
- –
- 50-Day Moving Average
- $4.43
- –
- 200-Day Moving Average
- $3.34
- –
- Average True Range (14)
- $0.44
- –
- Price Change (1 Week)
- 30.8%
- 0.99%
- Price Change (1 Month)
- 27.9%
- -3.52%
- Price Change (3 Months)
- 17.1%
- -7.86%
- Price Change (6 Months)
- 98.1%
- -1.12%
- Price Change (YTD)
- 115.1%
- -2.92%
- Price Change (1 Year)
- 58.5%
- -1.37%
- Price Change (3 Years)
- -27.7%
- 3.24%
- Price Change (5 Years)
- -75.8%
- -50.4%
- Average Volume (10 Days)
- 442,485
- –
- Average Volume (20 Days)
- 329,935
- –
- Average Volume (90 Days)
- 316,847
- –
- Relative Volume
- 0.90
- 0.76
- Relative Strength Index (14)
- 63.9
- 46.7
- Volatility (1 Year)
- 83.9%
- 64.2%
- Beta (5 Years)
- 1.70
- 1.04
MarginsIndustry
- EBITDA Margin
- -20.6%
- -2.52%
- FCF Margin
- -9.13%
- 0.65%
Returns on capitalIndustry
- Return on Equity (ROE)
- -74.0%
- -17.3%
- Return on Assets (ROA)
- -29.7%
- -12.3%
- Return on Invested Capital (ROIC)
- -46.4%
- -2.83%
- Return on Capital Employed (ROCE)
- -37.2%
- -8.13%
Financial positionIndustry
- Current Ratio
- 2.58
- 2.49
- Quick Ratio
- 1.52
- 1.53
- Debt / Equity
- 0.97
- 0.42
- Interest Coverage
- -8.17
- -1.63
GrowthIndustry
- Revenue Growth (YoY)
- -7.10%
- 9.42%
- Revenue Growth (3Y CAGR)
- 14.5%
- 7.08%
- Revenue Growth (5Y CAGR)
- 30.0%
- 11.8%
EfficiencyIndustry
- Asset Turnover
- 1.08
- 0.59
- Inventory Turnover
- 0.99
- 2.20
- Revenue Per Employee
- $451.88K
- $331.99K
- Profits Per Employee
- -$123.99K
- -$46.47K
- Employee Count
- 450
- 193
- WACC
- 12.8%
- 9.91%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- -$20.25M
- $3.95M
- Net Cash Per Share
- -$0.31
- $0.26
- Equity (Book Value)
- $61.65M
- $63.80M
- Book Value Per Share
- $0.95
- $3.26
- Tangible Book Value
- $42.42M
- $11.61M
- Working Capital
- $72.61M
- $57.32M
Cash flow (TTM)Industry
- Capital Expenditures
- -$9.83M
- -$3.94M
- FCF Per Share
- -$0.29
- -$0.00
Dividends and yieldsIndustry
- Earnings Yield
- -16.3%
- -4.76%
- FCF Yield
- -5.42%
- 0.28%
Taxes and interestIndustry
- Interest Expense
- $6.07M
- $5.40M
Scores and fair valueIndustry
- Altman Z-Score
- 0.15
- 2.47
- Piotroski F-Score
- 2
- 5
- Beneish M-Score
- -3.50
- -2.64
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | TMCI | S&P 500 | Difference | TMCI per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +28.5% | -3.0% | +31.6 pts | ||
| 3 months | +16.9% | -2.8% | +19.6 pts | ||
| Year to date | +115.1% | +11.5% | +103.6 pts | ||
| 1 year | +67.8% | +13.5% | +54.4 pts | ||
| 3 years | -12.6% | +77.7% | −90.3 pts | -4.4% | +21.1% |
| 5 years | -75.8% | +72.6% | −148.4 pts | -24.7% | +11.5% |
| 10 years | +78.6% | +308.2% | −229.5 pts | +6.0% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
2M TMCI shares were sold short on Oct 30, 2026, down 6.9% from the previous report, or 3.82% of the shares available to trade. At recent volumes it would take 8.7 days to buy them back. Over the last 20 sessions, 26.7% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 1,791,040 | -6.9% | 206,951 | 8.7 |
| Oct 15, 2026 | 1,924,027 | -2.7% | 230,786 | 8.3 |
| Sep 30, 2026 | 1,976,907 | +13.8% | 229,942 | 8.6 |
| Sep 15, 2026 | 1,736,595 | +11.3% | 205,255 | 8.5 |
| Aug 31, 2026 | 1,560,809 | -2.2% | 291,775 | 5.3 |
| Aug 14, 2026 | 1,596,168 | -6.1% | 537,531 | 3.0 |
| Jul 31, 2026 | 1,699,587 | -7.9% | 310,924 | 5.5 |
| Jul 15, 2026 | 1,844,752 | +5.5% | 515,177 | 3.6 |
| Jun 30, 2026 | 1,748,502 | -46.6% | 1,687,961 | 1.0 |
| Jun 15, 2026 | 3,271,388 | -20.4% | 721,951 | 4.5 |
| May 29, 2026 | 4,108,513 | +13.7% | 559,933 | 7.3 |
| May 15, 2026 | 3,613,472 | -8.8% | 581,688 | 6.2 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?